Hydrogen sulfide inhibits gene expression associated with aortic valve degeneration by inducing NRF2-related pro-autophagy effect in human aortic valve interstitial cells
Authors:
- 20 October 2023
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 479 (10) , 2653-2662
Abstract
Aortic valve stenosis (AS) is the most common valvular heart disease but there are currently no effective medical treatments that can delay disease progression due to a lack of knowledge of the precise pathophysiology. The expression of sulfide: quinone oxidoreductase (SQOR) and nuclear factor erythroid 2-related factor 2 (NRF2) was decreased in the aortic valve of AS patients. However, the role of SQOR and NRF2 in the pathophysiology of AS has not been found. We investigated the effects of hydrogen sulfide (H2S)-releasing compounds on diseased aortic valve interstitial cells (AVICs) to explain the cellular mechanism of SQOR and elucidate the medical value of H2S for AS treatment. Sodium hydrosulfide (NaHS) treatment increased the expression of SQOR and NRF2 gene and consequently induced the NRF2 target genes, such as NAD(P)H quinone dehydrogenase 1 and cystathionine γ-lyase. In addition, NaHS dose-dependently decreased the expression level of fibrosis and inflammation-related genes (MMP9, TNF-α, IL6) and calcification-related genes (ALP, osteocalcin, RUNX2, COL1A1) in human AVICs. Furthermore, NaHS activated the AMPK-mTOR pathway and inhibited the PI3K-AKT pathway, resulting in a pro-autophagy effect in human AVICs. An NRF2 inhibitor, brusatol, attenuated NaHS-induced AMPK activation and decreased the autophagy markers Beclin-1 and LC3AB, suggesting that the mechanism of action of H2S is related to NRF2. In conclusion, H2S decreased gene expression levels related to aortic valve degeneration and activated AMPK-mTOR-mediated pro-autophagy function associated with NRF2 in human AVICs. Therefore, H2S could be a potential therapeutic target for the development of AS treatment. Graphical abstractKeywords
Funding Information
- National Research Foundation of Korea (2019R1I1A2A01060702)
- Asan Institute for Life Sciences, Asan Medical Center (2022IF-0004)
This publication has 52 references indexed in Scilit:
- The Gasotransmitter Hydrogen Sulfide Induces Nrf2-Target Genes by Inactivating the Keap1 Ubiquitin Ligase Substrate Adaptor Through Formation of a Disulfide Bond Between Cys-226 and Cys-613Antioxidants & Redox Signaling, 2013
- Introduction to Aortic StenosisCirculation Research, 2013
- Decreased Endogenous Production of Hydrogen Sulfide Accelerates AtherosclerosisCirculation, 2013
- Hydrogen Sulfide Lowers Proliferation and Induces Protective Autophagy in Colon Epithelial CellsPLOS ONE, 2012
- Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That BlossomedPhysiological Reviews, 2012
- Hydrogen Sulfide: From Brain to GutAntioxidants & Redox Signaling, 2010
- Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tractDigestive and Liver Disease, 2010
- H 2 S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine γ-LyaseScience, 2008
- Hydrogen sulfide: third gaseous transmitter, but with great pharmacological potentialActa Pharmacologica Sinica, 2007
- Two's company, three's a crowd: can H 2 S be the third endogenous gaseous transmitter?The FASEB Journal, 2002